跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 30,342 条关于
“SCN1A+ Dravet syndrome”
全部
30,342
临床试验
26,245
药物
277
机构
20
资讯
3,800
去年
Encoded Therapeutics Receives FDA RMAT Designation for ETX101 Gene Therapy in Dravet Syndrome
15天前
Encoded Therapeutics' ETX101 Gene Therapy Shows Durable Seizure Reduction and Neurodevelopmental Gains in Dravet Syndrome
9天前
Encoded Therapeutics Raises $275M Series F to Push ETX101 Gene Therapy Through Pivotal Dravet Syndrome Development
9个月前
Encoded Therapeutics Reports 78% Seizure Reduction with ETX101 Gene Therapy in Dravet Syndrome Trial
去年
Biogen and Stoke Therapeutics Collaborate to Advance Zorevunersen for Dravet Syndrome
2年前
Stoke Therapeutics Advances Zorevunersen for Dravet Syndrome to Phase III After FDA Lifts Clinical Hold
去年
Zorevunersen Shows Promising Cognitive and Behavioral Improvements in Dravet Syndrome Phase 3 Trial Analysis
2年前
Stoke Therapeutics and Biogen Initiate Phase 3 EMPEROR Trial for Zorevunersen in Dravet Syndrome
6个月前
Experimental Drug Zorevunersen Shows Up to 91% Seizure Reduction in Children with Dravet Syndrome
10个月前
Stoke Therapeutics Advances Phase 3 Dravet Syndrome Trial with Strong Financial Position Through 2028
第 1 页,共 380 页
上一页
下一页